Latest Share Chat

REMOVE ADS

Hikma Pharmaceuticals Share News (HIK)

Hikma Pharmaceuticals Information

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes

Get Live Data

1,520.00 -20.00 (-1.30%)

Bid:

1,522.00

Ask:

1,524.00

Spread: 2.00 (0.131%)

Market Cap: £3.20b

Last checked at -

Intraday Hikma Pharmaceuticals Share Chart

REMOVE ADS

Hikma Pharmaceuticals News

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for C...

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compound...

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to c...

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's d...